UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 27, 2022
BioPower Operations Corporation
(Exact name of registrant as specified in its charter)
| Nevada | 333-172139 | 27-4460232 | ||
|
(State of other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
20801 Biscayne Blvd., Suite 403 Aventura, FL |
33180 | |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code): (786) 923-0272
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Current Report on Form 8-K contains forward-looking statements or statements which arguably imply or suggest certain things about our future. Statements which express that we “believe,” “anticipate,” “expect,” or “plan to,” and any other similar statements which are not historical fact, are forward-looking statements. These statements are based on assumptions that we believe are reasonable, but there are a number of factors that could cause our actual results to differ materially from those expressed or implied by these statements. You are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements speak as of the date hereof, and we do not undertake any obligation to update or revise any forward-looking statements, except as expressly required by law.
Item 8.01. Other Events.
During the first quarter of the fiscal year ending November 30, 2022, BioPower Operations Corporation (the “Company”) commenced operations and accordingly, the Company ceased to be a shell company, as such term is defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended.
As previously reported, on October 7, 2021, the Company filed a certificate of amendment to its amended and restated articles in order to change its corporate name from BioPower Operations Corporation to HyFi Corp (the “Name Change”). The Name Change is subject to clearance by the Financial Industry Regulatory Authority (FINRA). The Company has been in communication with FINRA regarding the Name Change and expects the Name Change to be effective in the coming weeks.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BioPower Operations Corporation | ||
| Date: January 27, 2022 | By: | /s/ Troy MacDonald |
| Troy MacDonald | ||
| Chief Executive Officer | ||